Premium
Tuberculosis complicating treatment of hepatitis C in an HIV‐infected haemophilia A patient
Author(s) -
KILLINGLEY B.,
BHAGANI S.,
SLAPAK G.,
YEE T. T.,
JOHNSON M.
Publication year - 2006
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2006.01289.x
Subject(s) - medicine , ribavirin , pegylated interferon , tuberculosis , hepatitis c , haemophilia , chronic hepatitis , human immunodeficiency virus (hiv) , adenitis , virology , immunology , dermatology , pediatrics , virus , pathology
Summary. Pegylated interferon (pegIFN)/ribavirin has been established as the treatment of choice for chronic hepatitis C in HIV co‐infected individuals [1–3]. We report the case of an individual who was well prior to treatment, but was diagnosed with tuberculous adenitis after receiving 12 weeks of pegIFN/ribavirin therapy. The association of pegIFN and ribavirin therapy with tuberculosis (TB) has not been described previously.